At Navidium sustainability is our Number 1 Value. The maritime industry needs to change to be feasible in the future as a global transport mechanism. We believe at Navidium we're building part of the puzzle to solve this problem by using exciting data-driven products that open up a world of interoperable possibilities and we're excited to be driving this change forward with our customers and partners. If you're excited by any of the following then make sure you get in touch- Blue Economy- Software Development (Kafka, k8s, .net, timeserie, MQTT, microservices)- Front End Development (Mainly React)- Maritime Industry- Data Science (Physics and ML based hybrid modeling)- Data Engineering- Voyage Optimisation- Performance Monitoring- Environmental Reporting

We are a remote company with a diverse team working across time zones. We are passionate about the products that we build. A global startup studio. We help inspiring founders build great companies! Ymir would love the chance to make your idea flourish. - Flexible Hours & Locations - You’re accountable for your work. That’s pretty much it! - Annual Company Retreat - We travel, we dance and we travel back. Then we’ll do it again next year. - Social Fridays - Once a month, we catch up, play games and glide into a well-deserved weekend. - Growth & Learning - Equipment, courses, conferences, or anything to help you. - Open Work Culture At Ymir, it’s all for one and one for all. We speak our minds and we listen.

Keenious - The new way of researching online Students and researchers all over the world spend a large part of their day searching for academic articles online, which requires experience and knowledge of how to access and handle complex academic search engines. Keenious is an online research tool solving this problem by finding relevant research to what you are working on, automatically. It achieves this by analyzing your document’s text with advanced machine learning and then displaying a list of highly relevant research articles right next to your document. Fits your workflow seamlessly and integrates into your workflow by analyzing your text live adding a brand-new dimension to your writing process, as well as enabling new and intuitive ways of finding relevant information. Because Keenious can find connections that you were not aware of, it further aids you in generating novel thoughts and ideas on how to take your research forward. Keenious has been designed from the start to be extremely easy to use for everyone no matter their academic level and is already successfully helping many students and researchers around the world. Try it for free! Keenious is available for free now for a limited time at [keenious.com](http://keenious.com) where you easily can add it to Microsoft Word and Google Docs. Download now to be one of the first to take advantage of this new way of researching online!

You will find 128 million contact lens users worldwide in a 7.5 billion dollar industry and most of them have trouble inserting and/ or removing contact lenses. The result can be as mild as red and irritating eyes and the need to use glasses for a couple of days, but also worst case scenario having to surgically remove the eye. We have designed and created a patented product for inserting and removing contact lenses with a container for keeping the product clean and sterile so you can take it with you.

Byndle AS is a Norwegian technology company based in Trondheim that makes public registry data accessible and useful. On byndle.no, we offer a business database, credit checks, prospecting, and vehicle and property data for business customers, based on data from sources including the Brønnøysund Register Centre, the Norwegian Tax Administration, and the Norwegian Public Roads Administration. On opplysning.byndle.no, we operate a free information service with searches for companies and phone numbers. The company was established in 2014 and is located at Beddingen 16 in Trondheim.

Babies grow out of clothing real fast. Parents want the best for their kids and for the planet that they will be growing up on. Add to this the fact that the production of clothing is extremly resource-intensive, and the fact that parents report that baby clothing is a real hassle, then you have a problem that needs a solution. That is where STAS comes in - we provide a digital service for baby clothing on a monthly subscription basis. Once the items are too small, our customers send them back, and then receive the next batch. All clothing items that are returned are processed and either re-used by other clients or re-cycled. We have tested the concept and received excellent user feedback, now we're getting rigged for full commerical expansion. if you're interested, please get in touch.

Ondego lets you charge your phone on the go through its network of portable batteries so you never have to worry about your battery level again. Users can find our chargers in cafés, restaurants, and other public locations where they can unlock a charger, charge wherever they want and later return to any Ondego station nearby. See this short video (1min) to see how it works:ondego.no

HØYDENDesignet i Bergen. Visjonen for klokkene har vært å oppnå et uttrykk langt utover det som er vanlig i dette prissegmentet. Høy kvalitet og utmerket finish, bygget med 100% sveitsisk urverk. Designet og utviklet av grunnlegger Kristian Høyden i Bergen, Norge.Krystallglass, 5ATM (vann), 316 Stainless Steel. Ronda urverk fra Sveits. (For ytterligere detaljer, vennligst besøk www.hoydentimepieces.no).

Grasp Your Future Our goal is to increase effectiveness and efficiency of medical treatments through person-centered care and improved clinician-patient communication. Grasp concept One-minute video presenting how Grasp works. Grasp Tracker A patented, CE-marked, and approved medical device. You simply squeeze the device when tracking your symptoms, behavior, and events. Grasp User app Through the user app, the doctor is connected to the patient´s everyday life in real-time: at home, at work, or while engaging in activities. Grasp Clinical solution The doctor can remotely and easily adjust the treatment, modify medical plans or give tailored behavioral feedback to increase the function of the patient

EKKO MEDIA ER NORGES FØRSTE DIGITALE MEDIEBYRÅ SPESIALISERT MOT EIENDOMSMARKEDET.Ekko leverer digitale markedsføringsløsninger for eiendomsprosjekter og meglere i hele Norge. Vi har fokus på utvikling av ny teknologi for å alltid ligge langt foran konkurrentene. Byrået ble startet opp i 2013 av gründerne Lars Henrik Sand og Asgeir Brude Wærås. De opplevde at eiendomsbransjen var preget av byråer som var sterke på fagfelt som 3D eller nettsider, men de så et behov for spesialisering av digital markedsføring. På kort tid har byrået vokst til en meget sterk aktør innen digital markedsføring, hvor mye av grunnen til den sterke veksten er byråets nysgjerrighet, engasjement og serviceinnstilling. Med disse egenskapene er Ekko Media alltid med på å skape nye metoder, strategier og markedsanalyser – som igjen gir et unikt fortrinn i et marked som aldri står stille.

At Aivero we strive to bring AI to industrial robotics. We are a young and dynamic startup with offices in Norway and Denmark Aivero is a Scandinavian startup founded in 2017 with a mission to democratize automation by simplifying robotic control to the point where anyone can deploy and operate them. No more code, programming, or complex path planning—vision-guided robotics automates this too.

CoreAll is developing game-changing core drilling technology for the E&P industry. The Intelligent Coring System includes real-time coring process control with true formation evaluation data and the ability to core and drill with the same bottom hole assembly. The system has been patented in multiple countries. The development of the main system has successfully been completed with support from Lundin Norway, Spirit Energy, DEA, The Research Council of Norway and Innovation Norway. The system has completed four successful field tests in test wells and is ready for commercial introduction. CoreAll is seeking investors to finance the commercial operations capability. CoreAll was one of only two SME winners of the prestigious Spotlight on Technology award at the OTC in Houston in May 2018.

We sleep on nature. Do you? COCO-MAT er en Internasjonal merkevare representert i 20 land, i mer enn 100 butikker. Du finner oss på over 700 hoteller rundt om i verden, blant annet Athens Sofitel, Landmark Hotel in London, Equinox Hotel i NY, Hidden Hotel in Paris, Ritz-Carlton Barcelona, Hotel De L’Europe Amsterdam og mange flere. Vi har dedikert oss til å produsere verdens beste senger, og de tilvirkes for hånd etter de beste bærekraftige prinsipper. En COCO-MAT madrass består av opp til 14 lag med naturlige materialer som sammen gir optimal og isometrisk støtte til kroppen. Alt uten bruk av metall fjærer, syntetiske stoffer eller annet som naturen ikke enkelt kan resirkulere. Vi skal tilby hoteller og overnattingsteder som tar bærekraft og gjestenes søvn og velvære på alvor de absolutt beste sengene. Vi kan tilby utprøvde konsepter som egen sengemeny og putemeny til utstilling i lobby. Sammen med morselskapet tilbyr vi komplett interiør til hotellrommet. Alle våre produkter er laget av fornybare, naturlige materialer som; kokosnøtt fibre, naturgummi, ull, bomull, kaktus fibre, tang, hestehår, silke, lin, tre og gåsedun. Våre senger er alle laget for hånd på vår egen fabrikk i Xanthi, nord i Hellas. Vi har forpliktet oss til å redusere miljøskadelige utslipp og levere naturlige, helsebringende produkter. Vi forbyr bruken av kjemikalier i eller på våre produkter, og benytter kun økologiske, ufarlige fargestoffer i de tilfellene produktet krever det. COCO-MAT strekker seg langt for å redusere avfall og rest-materialer til et minimum. Ved å investere i nye produksjonsmetoder har vi oppnådd en resirkuleringsgrad på hele 96%. Rester fra produksjonen blir benyttet til å lage andre produkter. Et eksempel på dette er naturgummi fra madrasser, som blir kuttet opp i flak og benyttes som innmat i hodeputer og puter i møbler. COCO-MAT NORSE AS er stiftet i 2017 og er en franchise av COCO-MAT, og representerer merkevaren i Norge.

RESPINOR is a privately-owned medical device company, founded in Oslo, 2015. We have developed an objective measure of breathing for critically ill patients within intensive care. The technology provides precise, continuous and real-time information of diaphragm function, our main breathing muscle, to increase the quality of care and reducing costs. RESPINOR’s technology is the winner of Horizon 2020 both in phase I and II. We are addressing an unmet medical need because every breath counts.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.